CRS News and Press, Carpenter Technology Corporation From 07/29/21

Carpenter Technology (NYSE:CRS): FQ4 Non-GAAP EPS of -$0.28 beats by $0.22; GAAP EPS of -$1.18 misses by $0.41. Revenue of $421.6M (-3.6% Y/Y) beats by $34.6M. CEO comment: “Looking ahead, our focus is centered on capitalizing on emerging opportunities across our end-use markets as con...

PHILADELPHIA, July 29, 2021 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) (the “Company”) today announced financial results for the fiscal fourth quarter and year ended June 30, 2021. For the quarter, the Company reported a net loss of $57.1 million, or $1.1...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Bristol Myers Squibb (BMY) announces that the EMA's Committee for Medicinal Products for Human Use ((CHMP)) has recommended granting Conditional Marketing Authorization for Abecma (idecabtagene vicleucel; ide-cel), the company’s BCMA-directed chimeric antigen receptor ((CAR)) T cell im...

PHILADELPHIA, June 14, 2021 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) today announced that Dr. David Graf has been appointed to lead Carpenter Technology’s Specialty Alloys Operations (SAO) business segment as Vice President and Group President – SA...

Precision BioSciences (DTIL) announces progress on two strategies designed to optimize the durability of allogeneic CAR T therapy in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma ((NHL)).The Company reported updated interim results from its Phase 1/2a study of PBCAR0191, an inv...

Carpenter Technology Corporation (CRS) will increase base prices by 6% to 9% on new, non-contract orders across all specialty alloy products.The increases will be effective with new orders placed after May 24, 2021.Press Release For further details see: Carpenter Technology to raise bas...

PHILADELPHIA, May 24, 2021 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) announced today that it will increase base prices six percent (6%) to nine percent (9%) on new, non-contract orders across all specialty alloy products. The increases will be effective with new order...